Diagnostic Performance of [(18)F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer

Positron emission tomography using [(18)F]fluorodeoxyglucose (FDG PET) potentially underperforms for staging of patients with grade 1–2 estrogen receptor positive (ER+) breast cancer. The aim of this study was to retrospectively investigate the diagnostic accuracy of FDG PET in this patient populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Ramsha, Mammatas, Lemonitsa H., Aras, Tuba, Vogel, Wouter V., van de Brug, Tim, Oprea-Lager, Daniela E., Verheul, Henk M. W., Hoekstra, Otto S., Boellaard, Ronald, Menke-van der Houven van Oordt, Catharina W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625348/
https://www.ncbi.nlm.nih.gov/pubmed/34829301
http://dx.doi.org/10.3390/diagnostics11111954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625348/
https://www.ncbi.nlm.nih.gov/pubmed/34829301
http://dx.doi.org/10.3390/diagnostics11111954

Ejemplares similares